These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2502064)

  • 101. Influence of the developmental state of valvular lesions on the antimicrobial activity of cefotaxime in experimental enterococcal infections.
    Sullam PM; Drake TA; Täuber MG; Hackbarth CJ; Sande MA
    Antimicrob Agents Chemother; 1985 Mar; 27(3):320-3. PubMed ID: 3922293
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Comment on: Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?
    Giuliano S; Angelini J; Flammini S; Tascini C
    J Antimicrob Chemother; 2022 Jun; 77(7):2044-2045. PubMed ID: 35373298
    [No Abstract]   [Full Text] [Related]  

  • 103. Renal pharmacokinetic changes of gentamicin during enterococcal pyelonephritis.
    Auclair P; Lessard C; Bergeron MG
    Antimicrob Agents Chemother; 1988 May; 32(5):736-9. PubMed ID: 3134849
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?-authors' response.
    Flateau C; Riazi A; Cassard B; Camus M; Diamantis S
    J Antimicrob Chemother; 2022 Jun; 77(7):2045-2046. PubMed ID: 35474476
    [No Abstract]   [Full Text] [Related]  

  • 105. Comparison of vancomycin and penicillin for viral isolation.
    Forrer CB; Blahy OM; Maiatico AL; Campos JM; Friedman HM
    J Clin Microbiol; 1982 Aug; 16(2):295-8. PubMed ID: 7119101
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Effect of Enterococcus faecalis pyelonephritis on the intracortical accumulation kinetics of gentamicin in rats.
    Jullien M; Thériault G; Bergeron MG; Beauchamp D
    Can J Infect Dis; 1990; 1(4):117-20. PubMed ID: 22553452
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Treatment of
    Herrera-Hidalgo L; Fernández-Rubio B; Luque-Márquez R; López-Cortés LE; Gil-Navarro MV; de Alarcón A
    Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107066
    [TBL] [Abstract][Full Text] [Related]  

  • 108. d-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models.
    Fox DJ; Cooper MD; Speil CA; Roberts MH; Yanik SC; Meech RP; Hargrove TL; Verhulst SJ; Rybak LP; Campbell KC
    J Cyst Fibros; 2016 Jul; 15(4):518-30. PubMed ID: 26166286
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Versatility of aminoglycosides and prospects for their future.
    Vakulenko SB; Mobashery S
    Clin Microbiol Rev; 2003 Jul; 16(3):430-50. PubMed ID: 12857776
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Increasing Antimicrobial Resistance: Therapeutic Implications for Enterococcal Infections.
    Levison ME; Mallela S
    Curr Infect Dis Rep; 2000 Oct; 2(5):417-423. PubMed ID: 11095886
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Postantibiotic effect of ceftriaxone and gentamicin alone and in combination on Klebsiella pneumoniae, Pseudomonas aeruginosa and Streptococcus viridans.
    Buxbaum A; Georgopoulos A
    Infection; 1996; 24(6):459-64. PubMed ID: 9007594
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.
    Gavaldà J; Cardona PJ; Almirante B; Capdevila JA; Laguarda M; Pou L; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1996 Jan; 40(1):173-8. PubMed ID: 8787901
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.
    Gavaldà J; Pahissa A; Almirante B; Laguarda M; Crespo E; Pou L; Fernández F
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2098-103. PubMed ID: 8540723
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis.
    Francioli PB; Glauser MP
    Antimicrob Agents Chemother; 1993 Feb; 37(2):207-12. PubMed ID: 8452350
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.
    Blatter M; Fluckiger U; Entenza J; Glauser MP; Francioli P
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1971-6. PubMed ID: 8239615
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides.
    Zhanel GG; Craig WA
    Clin Pharmacokinet; 1994 Nov; 27(5):377-92. PubMed ID: 7851055
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Gentamicin volume of distribution in critically ill septic patients.
    Triginer C; Izquierdo I; Fernández R; Rello J; Torrent J; Benito S; Net A
    Intensive Care Med; 1990; 16(5):303-6. PubMed ID: 2212254
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis.
    Fantin B; Carbon C
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2387-91. PubMed ID: 2128443
    [TBL] [Abstract][Full Text] [Related]  

  • 119. In vivo antibiotic synergism: contribution of animal models.
    Fantin B; Carbon C
    Antimicrob Agents Chemother; 1992 May; 36(5):907-12. PubMed ID: 1510412
    [No Abstract]   [Full Text] [Related]  

  • 120. Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis.
    Saleh-Mghir A; Cremieux AC; Vallois JM; Muffat-Joly M; Devine C; Carbon C
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2403-7. PubMed ID: 1489184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.